2026 NPPES data Nurse Practitioner NPI 1942781257 NP
Verify on CMS →

AMAKA AKINADE, NP

Nurse Practitioner in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
116
Medicare Part D claims · 52 beneficiaries · Nurse Practitioner avg: 1K
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$226.22
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: AMAKA AKINADE, NP is a Nurse Practitioner ([object Object]) practicing in HOUSTON, Texas with a Medicare Part D prescribing footprint of 116 claims across 52 beneficiaries — 13% brand-name prescribing . Industry payments of $226.22 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: AMAKA AKINADE, NP filed 116 Medicare Part D claims in 2023 across HOUSTON, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

AMAKA AKINADE, NP at a glance

Quality data not reported

NPI registry status

Active

Issued 08/24/2018

NPI 1942781257

Primary specialty

Nurse Practitioner

High-volume

87,227 US NPIs in this specialty

Medicare Part D claims

116 89% vs specialty avg

2023 prescription claims

Specialty avg: 1,084

Specialty distribution in Texas

How Nurse Practitioner compares to other specialties among Texas providers

Texas providers

Nurse Practitioner share within Texas

1. Nurse Practitioner42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nurse Practitioner share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Nurse Practitioner (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Nurse Practitioner ABMS/AOA estimate

Est. board-certified rate (Nurse Practitioner) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Nurse Practitioner) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

AMAKA AKINADE, NP is a Nurse Practitioner provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: NP. NPI: 1942781257. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

AMAKA AKINADE, NP appears in the CMS NPPES registry as a Nurse Practitioner provider holding NP credentials at 560 MEYERLAND PLAZA MALL, HOUSTON, TX, 77096, with a listed phone of (713) 442-3222. NPI 1942781257 was issued on 08/24/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AKINADE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 116 prescription claims written by this provider, covering 52 Medicare beneficiaries and totaling roughly $7K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 12.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Nurse Practitioner is a high-volume specialty nationwide, with 87,227 enrolled providers across 56 states and an average of 1,084 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

560 MEYERLAND PLAZA MALL
HOUSTON, TX 77096

Provider Details

NPI 1942781257
Specialty Nurse Practitioner
Credentials NP
Gender Female
NPI Issued 08/24/2018

Hospital and facility affiliations

Facilities where AMAKA AKINADE, NP bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

KELSEY-SEYBOLD MEDICAL GROUP, PLLC
HOUSTON, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for AMAKA AKINADE, NP. Source: openpaymentsdata.cms.gov.

Total received

$226

Largest payer

COLOPLAST CORP

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to AMAKA AKINADE, NP. To verify AMAKA AKINADE, NP's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

AMAKA AKINADE, NP — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 116 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

116
Total Claims
$7K
Total Drug Cost
52
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
125
Total Day Supply
2,541
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$6K
Generic Drug Cost
$968
Opioid Claims
15 (12.9% rate)
Antibiotic Claims
26

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
2.98
Gender Split
37% female / 63% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Triamcinolone Acetonide
27
Nystatin
14
Santyl
Collagenase Clostridium Hist.
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nurse Practitioner Overview

How AMAKA AKINADE, NP fits within the Nurse Practitioner landscape nationally.

87,227
Nurse Practitioner Providers in US
56
States with Nurse Practitioner
1,084
Avg Claims per Provider

AMAKA AKINADE, NP's 116 claims are below the specialty average of 1,084.

Nearby Nurse Practitioner Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as AKINADE.

Compare Nurse Practitioner nationally: see state-by-state distribution →

Frequently Asked Questions

What is AMAKA AKINADE, NP's specialty?
AMAKA AKINADE, NP specializes in Nurse Practitioner and practices in HOUSTON, Texas. Credentials: NP.
How much does AMAKA AKINADE, NP prescribe under Medicare Part D?
In 2023, AMAKA AKINADE, NP wrote 116 Medicare Part D claims totaling $7K in drug costs for 52 beneficiaries.
Where is AMAKA AKINADE, NP located?
AMAKA AKINADE, NP is located at 560 MEYERLAND PLAZA MALL, HOUSTON, TX, 77096. Phone: (713) 442-3222.
What is AMAKA AKINADE, NP's NPI number?
AMAKA AKINADE, NP's National Provider Identifier (NPI) is 1942781257, issued on 08/24/2018.
Does AMAKA AKINADE, NP prescribe more brand-name or generic drugs?
AMAKA AKINADE, NP's prescribing is 13% brand-name and 87% generic drugs by claim count, with $6K in brand drug costs.
Does AMAKA AKINADE, NP prescribe opioids?
Yes, AMAKA AKINADE, NP had 15 opioid claims in 2023 with an opioid prescribing rate of 12.9%.
How many Nurse Practitioner providers are there in the US?
There are 87,227 Nurse Practitioner providers across 56 states in the US. The average Nurse Practitioner provider writes 1,084 Medicare Part D claims per year.
What drugs does AMAKA AKINADE, NP prescribe most often?
Based on 2023 Medicare Part D data, AMAKA AKINADE, NP's most frequently prescribed drugs include Triamcinolone Acetonide, Nystatin, Santyl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does AMAKA AKINADE, NP accept Medicare?
AMAKA AKINADE, NP appears in CMS Medicare data with 116 Part D claims and 52 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify AMAKA AKINADE, NP's credentials?
AMAKA AKINADE, NP's NPI is 1942781257 with credentials NP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology